scispace - formally typeset
S

Steven P. Gygi

Researcher at Harvard University

Publications -  778
Citations -  147003

Steven P. Gygi is an academic researcher from Harvard University. The author has contributed to research in topics: Proteome & Phosphorylation. The author has an hindex of 172, co-authored 704 publications receiving 129173 citations. Previous affiliations of Steven P. Gygi include University of Rochester Medical Center & Cell Signaling Technology.

Papers
More filters
Journal ArticleDOI

Fat cells directly sense temperature to activate thermogenesis

TL;DR: It is reported that cool temperature can directly activate a thermogenic gene program in adipocytes in a cell-autonomous manner, independent of the canonical cAMP/Protein Kinase A/cAMP response element-binding protein pathway downstream of the β-adrenergic receptors.
Journal ArticleDOI

Proteome analysis: Biological assay or data archive?

TL;DR: It is concluded that proteome analysis is an essential tool in the understanding of regulated biological systems and will continue to be enhanced by further improvements in analytical technology.
Journal ArticleDOI

Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics

TL;DR: This review summarizes advances involving the identification of ubiquitinated proteins, the elucidation of ubiqu itin-modification sites and the determination of polyubiquitin chain linkages, as well as offering a perspective on the application of emerging technologies for mechanistic and functional studies of protein ubiquitination.
Journal ArticleDOI

Quantitative proteomic analysis reveals posttranslational responses to aneuploidy in yeast

TL;DR: It is shown that although protein levels largely scale with gene copy number, subunits of multi-protein complexes are notable exceptions and posttranslational mechanisms attenuate their expression when their encoding genes are in excess.
Journal ArticleDOI

Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors

TL;DR: In this paper, stable isotope-based quantitative MS was used to globally monitor the kinetics of complex, ordered phosphorylation events on protein players in the canonical mitogen-activated protein kinase signaling pathway.